Provided by Tiger Trade Technology Pte. Ltd.

Amgen

381.50
+4.151.10%
Pre-market: 379.54-1.9600-0.51%06:37 EDT
Volume:2.71M
Turnover:1.03B
Market Cap:205.43B
PE:23.70
High:384.61
Open:381.94
Low:376.76
Close:377.35
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.79
T/O Rate:0.51%
Dividend:9.80
Dividend Rate:2.57%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:17.58
PE(LYR):26.81

Loading ...

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Dow Jones
·
Aug 19

Amgen is Maintained at Buy by Argus Research

Dow Jones
·
Aug 19

BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer

Reuters
·
Aug 19

Amgen Inc : Argus Research Raises Target Price to $460

THOMSON REUTERS
·
Aug 19

Morgan Stanley Adjusts Price Target on Amgen to $362 From $351, Keeps Equalweight Rating

MT Newswires Live
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

TScan Therapeutics Faces Loss of Key Amgen Partnership

TIPRANKS
·
Aug 19

TScan Therapeutics - Amgen to Terminate Research Collaboration and License Agreement with TScan Therapeutics - SEC Filing

THOMSON REUTERS
·
Aug 19

The Bull Case For Amgen (AMGN) Could Change Following Raised 2026 Earnings Guidance And Q2 Beat - Learn Why

Simply Wall St.
·
Aug 19

Trump's Privateer Hacking Plan Brings High Risk to Companies Taking Part

Dow Jones
·
Aug 18

Amgen Price Target Raised to $400.00/Share from $350.00 by Cantor Fitzgerald

Dow Jones
·
Aug 18

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 18

Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.

TIPRANKS
·
Aug 15

Amgen Targets Autoimmune Hepatitis With New Inebilizumab Trial

TIPRANKS
·
Aug 15

Amgen Price Target Raised to $380.00/Share from $360.00 by Barclays

Dow Jones
·
Aug 14

Barclays Reaffirms Their Hold Rating on Amgen (AMGN)

TIPRANKS
·
Aug 14

Sino Biopharmaceutical Stock Falls 2.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 14

U.S. Research Roundup-Cisco, Fox Corp, Target

Reuters
·
Aug 14

Amgen SVP Business Development Rachna Khosla Sells Common Shares Worth $1.67 Million

Reuters
·
Aug 14

Barclays Adjusts Price Target on Amgen to $380 From $360, Maintains Equalweight Rating

MT Newswires Live
·
Aug 13